Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer

Conditions: Recurrent Ovarian Carcinoma Interventions: Procedure: Carboplatin or cisplatin; Drug: Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar; Drug: Bevacizumab or biosimilar; Procedure: Cytoreductive surgery Sponsors: The University of Hong Kong Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials